UniSa - IRIS Institutional Research Information System

MAROTTA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.880
SA - Sud America 959
NA - Nord America 846
EU - Europa 252
AF - Africa 60
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.001
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.508
US - Stati Uniti d'America 787
BR - Brasile 719
SG - Singapore 488
VN - Vietnam 457
CN - Cina 209
AR - Argentina 91
FR - Francia 61
ID - Indonesia 53
EC - Ecuador 37
IT - Italia 34
PY - Paraguay 33
CO - Colombia 32
MX - Messico 31
IN - India 30
BD - Bangladesh 26
DE - Germania 22
GB - Regno Unito 19
UA - Ucraina 18
CL - Cile 17
RU - Federazione Russa 17
TR - Turchia 17
IQ - Iraq 16
KR - Corea 16
ZA - Sudafrica 13
PL - Polonia 12
VE - Venezuela 12
MA - Marocco 11
EG - Egitto 10
JP - Giappone 10
UY - Uruguay 10
CA - Canada 9
ES - Italia 8
KE - Kenya 8
NL - Olanda 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
LT - Lituania 6
PE - Perù 6
AL - Albania 5
PH - Filippine 5
PK - Pakistan 5
UZ - Uzbekistan 5
AT - Austria 4
AZ - Azerbaigian 4
MY - Malesia 4
RS - Serbia 4
SA - Arabia Saudita 4
SE - Svezia 4
CR - Costa Rica 3
DZ - Algeria 3
FI - Finlandia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
HR - Croazia 2
JM - Giamaica 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.999
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.506
San Jose 261
Ho Chi Minh City 174
Singapore 161
Dallas 144
Hanoi 103
Ashburn 81
Council Bluffs 72
São Paulo 62
Beijing 60
Lauterbourg 52
Rio de Janeiro 29
Da Nang 25
Haiphong 25
New York 18
Curitiba 17
Santa Clara 17
Asunción 16
Boardman 16
Los Angeles 15
Mexico City 14
Seoul 14
Thái Bình 14
Porto Alegre 13
Quito 12
Brasília 11
Ribeirão Preto 11
Woodbridge 11
Biên Hòa 10
Guayaquil 10
Ninh Bình 10
Salvador 10
Santo André 10
Naples 9
Phủ Lý 9
Santiago 9
Tokyo 9
Ann Arbor 8
Buenos Aires 8
Guarulhos 8
Montevideo 8
Orem 8
Buffalo 7
Cairo 7
Campinas 7
Frankfurt am Main 7
Hortolândia 7
Jakarta 7
Manaus 7
Medellín 7
Munich 7
Baghdad 6
Belo Horizonte 6
Bắc Giang 6
Caxias do Sul 6
Chandler 6
Cuiabá 6
Hải Dương 6
Jacksonville 6
Johannesburg 6
Maceió 6
Nairobi 6
Piracicaba 6
Recife 6
Volta Redonda 6
Warsaw 6
Bắc Ninh 5
Canoas 5
Coimbatore 5
Dublin 5
Houston 5
Izmir 5
Kyiv 5
Montreal 5
Nha Trang 5
Nuremberg 5
Poplar 5
Rome 5
San Juan 5
Santiago de Cali 5
Sumaré 5
Taiyuan 5
Tashkent 5
Araçatuba 4
Baku 4
Bauru 4
Caracas 4
Charlotte 4
Duque de Caxias 4
Feira de Santana 4
Fisciano 4
Florianópolis 4
Formosa 4
Gdansk 4
Ha Long 4
Huế 4
Joinville 4
Juiz de Fora 4
Limeira 4
Manchester 4
Totale 6.386
Salva come PNG Salva come JPEG
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 721
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 484
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 396
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 328
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 322
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 319
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 316
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 274
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 266
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 241
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 205
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 192
GH provocative tests stimulate the growth in children with idiopathic short stature 177
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 156
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 141
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 132
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 120
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 117
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 115
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 108
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 104
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 101
Benign thyroid nodules with RAS mutation grow faster 95
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 94
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 89
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 84
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 82
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 81
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 80
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 80
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 79
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 77
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 77
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 76
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 75
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 74
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 71
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 69
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 68
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 66
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 65
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 63
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 63
Radioiodide induces apoptosis in human thyroid tissue in culture 62
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 61
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 61
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 60
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 59
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 59
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 56
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 55
The evolving field of kinase inhibitors in thyroid cancer 55
Growing thyroid nodules with benign histology and RET rearrangement 55
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 54
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 51
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 51
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 51
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 49
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 49
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 47
Limitations of Chromogranin A in clinical practice 46
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 43
Hepatic arterial embolization in patients with neuroendocrine tumors 41
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context 26
La diagnostica molecolare del nodulo tiroideo 25
Beyond the Genome: Can Epigenetics Forecast Therapeutic Success in Graves’ Disease and Thyroid Eye Disease? 12
Totale 8.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20267.998 586 2.769 2.215 1.004 335 101 259 203 193 333 0 0
Totale 8.071